Annual Report

The report describes a year in which the company awarded DKK 217 million through 68 grants based on 247 applications. It also established a clear sustainability approach across its commercial and philanthropic activities, supported by an initial materiality assessment and four sustainability themes. LEO Pharma reported a 39% reduction in Scope 1 and 2 CO2e emissions against its 2019 baseline, while the Foundation continued its responsible investment and ownership activities.